Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly
International Journal of Molecular Sciences · 09.04.2025 · 26 (8) · 3520
DOI: 10.3390/ijms26083520 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.04.2025. Verfasst von Farah Issa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Health Sciences, QU Health Sector, Qatar University, Doha 2713, Qatar. Hauptthemen laut MEDLINE: Inflammasomes, Rheumatic Diseases, Rheumatic Heart Disease, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar University.
Abstract (Originalsprache)
Cardio-rheumatology is an evolving and interdisciplinary field lying at the intersection of rheumatology and cardiovascular medicine that recognizes that individuals with autoimmune and inflammatory rheumatic complications have a much higher likelihood of developing cardiovascular diseases (CVDs). Inflammasomes are multiprotein complexes stimulated by the immune system after the detection of pathogens or cellular injury. Inflammasomes undergo a two-stage activation process initiated by nuclear factor (NF)-κB, subsequently playing a crucial role in innate immunity through activation of caspase 1 and the consequent release of proinflammatory cytokines such as IL-18 and IL-1β. However, a loss of control of inflammasome activation can cause inflammatory diseases in humans. Recent studies have focused on the role of inflammasomes in inflammatory cascades implicated in the pathogenesis of several diseases. Here, we review inflammasome activation, its mechanism of action, and its role in CVD. In particular, we describe the role of inflammasomes in rheumatic heart disease, Kawasaki disease, familial Mediterranean fever, ankylosing spondylitis, and rheumatoid arthritis as exemplars to illustrate pathobiological mechanisms and the potential for targeting inflammasomes for therapeutic benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Health Sciences, QU Health Sector, Qatar University, Doha 2713, Qatar.
- Department of Pediatric, College of Medicine, Taibah University, Madinah 41477, Saudi Arabia.
- Department of Pharmaceutical Sciences, College of Pharmacy, QU Health Sector, Qatar University, Doha 2713, Qatar.
ORCID-Profile: Marah Abdulla, Hanin Alhiraky, Amal Al-Haidose, Atiyeh M Abdallah
Förderung
- Qatar University
Zitieren
APA
Issa, F., Abdulla, M., Retnowati, F. D., Al-Khawaga, H., Alhiraky, H., Al-Harbi, K. M., Al-Haidose, A., Maayah, Z. H., & Abdallah, A. M. (2025). Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly. International Journal of Molecular Sciences, 26(8), 3520. https://doi.org/10.3390/ijms26083520
Vancouver
Issa F, Abdulla M, Retnowati FD, Al-Khawaga H, Alhiraky H, Al-Harbi KM, et al. Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly. International Journal of Molecular Sciences. 2025;26(8):3520. doi:10.3390/ijms26083520
BibTeX
@article{Issa2025,
author = {Issa, Farah and Abdulla, Marah and Retnowati, Faizah D and Al-Khawaga, Huda and Alhiraky, Hanin and Al-Harbi, Khalid M and Al-Haidose, Amal and Maayah, Zaid H and Abdallah, Atiyeh M},
title = {Cardio-Rheumatic Diseases: Inflammasomes Behaving Badly},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3520},
doi = {10.3390/ijms26083520}
}
EUVIMED